Response to Pentagastrin After Acute Phenylalanine and Tyrosine Depletion in Healthy Men: a Pilot Study

Overview

Journal J Psychiatry Neurosci

Specialty Psychiatry

Date 2001 Jun 8

PMID 11394194

Citations 2

Authors

N Coupland

L Zedkova

G Sanghera

M Leyton

J M Le Melledo

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the effects of the acute depletion of the catecholamine precursors phenylalanine and tyrosine on mood and pentagastrin-induced anxiety.

Design: Randomized, double-blind controlled multiple crossover study.

Setting: University department of psychiatry.

Participants: 6 healthy male volunteers.

Interventions: 3 treatments were compared: pretreatment with a nutritionally balanced amino acid mixture, followed 5 hours later by a bolus injection of normal saline placebo; pretreatment with a balanced amino acid mixture, followed by a bolus injection of pentagastrin (0.6 microgram/kg); and pretreatment with an amino acid mixture without the catecholamine precursors phenylalanine or tyrosine, followed by pentagastrin (0.6 microgram/kg).

Outcome Measures: Scores on the panic symptom scale, a visual analogue scale for anxiety, the Borg scale of respiratory exertion and the Profile of Mood States Elation-Depression Scale.

Results: Pentagastrin produced the expected increases in anxiety symptoms, but there was no significant or discernible influence of acute phenylalanine and tyrosine depletion on anxiety or mood.

Conclusions: These pilot data do not support further study using the same design in healthy men. Under these study conditions, phenylalanine and tyrosine depletion may have larger effects on dopamine than noradrenaline. Alternative protocols to assess the role of catecholamines in mood and anxiety are proposed.

Citing Articles

Dietary tyrosine/phenylalanine depletion effects on behavioral and brain signatures of human motivational processing.

Bjork J, Grant S, Chen G, Hommer D Neuropsychopharmacology. 2013; 39(3):595-604.

PMID: 23995581 PMC: 3895237. DOI: 10.1038/npp.2013.232.

Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion.

Leyton M, Aan Het Rot M, Booij L, Baker G, Young S, Benkelfat C J Psychiatry Neurosci. 2007; 32(2):129-36.

PMID: 17353942 PMC: 1810580.

References

SJOERDSMA A, Engelman K, Spector S, UDENFRIEND S . Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. Lancet. 1965; 2(7422):1092-4. DOI: 10.1016/s0140-6736(65)90062-0. View

Leyton M, Young S, Blier P, Baker G, Pihl R, Benkelfat C . Acute tyrosine depletion and alcohol ingestion in healthy women. Alcohol Clin Exp Res. 2000; 24(4):459-64. View

Carlsson A, Lindqvist M . Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1978; 303(2):157-64. DOI: 10.1007/BF00508062. View

Lorr M, McNAIR D, Fisher S . Evidence for bipolar mood states. J Pers Assess. 1982; 46(4):432-6. DOI: 10.1207/s15327752jpa4604_16. View

Borg G . Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14(5):377-81. View

Coupland N, Glue P, Nutt D . Challenge tests: assessment of the noradrenergic and GABA systems in depression and anxiety disorders. Mol Aspects Med. 1992; 13(3):221-47. DOI: 10.1016/0098-2997(92)90011-n. View

McCann U, Penetar D, Shaham Y, Thorne D, Sing H, Thomas M . Effects of catecholamine depletion on alertness and mood in rested and sleep deprived normal volunteers. Neuropsychopharmacology. 1993; 8(4):345-56. DOI: 10.1038/npp.1993.34. View

Bradwejn J, Koszycki D . The cholecystokinin hypothesis of anxiety and panic disorder. Ann N Y Acad Sci. 1994; 713:273-82. DOI: 10.1111/j.1749-6632.1994.tb44075.x. View

McCann U, Thorne D, Hall M, Popp K, AVERY W, Sing H . The effects of L-dihydroxyphenylalanine on alertness and mood in alpha-methyl-para-tyrosine-treated healthy humans. Further evidence for the role of catecholamines in arousal and anxiety. Neuropsychopharmacology. 1995; 13(1):41-52. DOI: 10.1016/0893-133X(94)00134-L. View

10.

Pitchot W, Hansenne M, Gonzalez Moreno A, Wauthy J, Ansseau M . [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines]. Acta Psychiatr Belg. 1995; 95(4-5):210-33. View

11.

Moja E, Lucini V, Benedetti F, Lucca A . Decrease in plasma phenylalanine and tyrosine after phenylalanine-tyrosine free amino acid solutions in man. Life Sci. 1996; 58(26):2389-95. DOI: 10.1016/0024-3205(96)00242-1. View

12.

van Megen H, Westenberg H, den Boer J, Kahn R . Cholecystokinin in anxiety. Eur Neuropsychopharmacol. 1996; 6(4):263-80. DOI: 10.1016/s0924-977x(96)00038-7. View

13.

Coupland N, Lillywhite A, Bell C, Potokar J, Nutt D . A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder. Biol Psychiatry. 1997; 41(9):988-90. DOI: 10.1016/S0006-3223(97)00043-7. View

14.

Kellner M, Yassouridis A, Jahn H, Wiedemann K . Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder. Psychopharmacology (Berl). 1997; 133(1):55-61. DOI: 10.1007/s002130050371. View

15.

Reilly J, McTavish S, Young A . Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J Psychopharmacol. 1997; 11(4):381-92. DOI: 10.1177/026988119701100416. View

16.

Palmour R, Ervin F, Baker G, Young S . An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology (Berl). 1998; 136(1):1-7. DOI: 10.1007/s002130050532. View

17.

Carpenter L, Anderson G, Pelton G, Gudin J, Kirwin P, Price L . Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology. 1998; 19(1):26-35. DOI: 10.1016/S0893-133X(97)00198-X. View

18.

Neumeister A, Turner E, Matthews J, Postolache T, Barnett R, Rauh M . Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry. 1998; 55(6):524-30. DOI: 10.1001/archpsyc.55.6.524. View

19.

Charney D . Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry. 1998; 59 Suppl 14:11-4. View

20.

Stein M . Neurobiological perspectives on social phobia: from affiliation to zoology. Biol Psychiatry. 1998; 44(12):1277-85. DOI: 10.1016/s0006-3223(98)00265-0. View